113 related articles for article (PubMed ID: 21453717)
1. Transcriptional activation of the senescence regulator Lsh by E2F1.
Niu J; Chen T; Han L; Wang P; Li N; Tong T
Mech Ageing Dev; 2011 Apr; 132(4):180-6. PubMed ID: 21453717
[TBL] [Abstract][Full Text] [Related]
2. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
4. Senescence delay and repression of p16INK4a by Lsh via recruitment of histone deacetylases in human diploid fibroblasts.
Zhou R; Han L; Li G; Tong T
Nucleic Acids Res; 2009 Aug; 37(15):5183-96. PubMed ID: 19561196
[TBL] [Abstract][Full Text] [Related]
5. E2F1 contributes to the transcriptional activation of the KIR3DL1 gene.
Gao XN; Yu L
Biochem Biophys Res Commun; 2008 Jun; 370(3):399-403. PubMed ID: 18358829
[TBL] [Abstract][Full Text] [Related]
6. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
Araki K; Nakajima Y; Eto K; Ikeda MA
Oncogene; 2003 Oct; 22(48):7632-41. PubMed ID: 14576826
[TBL] [Abstract][Full Text] [Related]
7. 8-Chloro-adenosine-induced E2F1 promotes p14ARF gene activation in H1299 cells through displacing Sp1 from multiple overlapping E2F1/Sp1 sites.
Zhang HJ; Li WJ; Yang SY; Li SY; Ni JH; Jia HT
J Cell Biochem; 2009 Feb; 106(3):464-72. PubMed ID: 19115249
[TBL] [Abstract][Full Text] [Related]
8. P300 plays a role in p16(INK4a) expression and cell cycle arrest.
Wang X; Pan L; Feng Y; Wang Y; Han Q; Han L; Han S; Guo J; Huang B; Lu J
Oncogene; 2008 Mar; 27(13):1894-904. PubMed ID: 17906698
[TBL] [Abstract][Full Text] [Related]
9. Transcription factor E2F1 is a potent transactivator of the insulin-like growth factor-I receptor (IGF-IR) gene.
Schayek H; Bentov I; Rotem I; Pasmanik-Chor M; Ginsberg D; Plymate SR; Werner H
Growth Horm IGF Res; 2010 Feb; 20(1):68-72. PubMed ID: 19703789
[TBL] [Abstract][Full Text] [Related]
10. Chromatin Remodeling Factor LSH is Upregulated by the LRP6-GSK3β-E2F1 Axis Linking Reversely with Survival in Gliomas.
Xiao D; Huang J; Pan Y; Li H; Fu C; Mao C; Cheng Y; Shi Y; Chen L; Jiang Y; Yang R; Liu Y; Zhou J; Cao Y; Liu S; Tao Y
Theranostics; 2017; 7(1):132-143. PubMed ID: 28042322
[TBL] [Abstract][Full Text] [Related]
11. The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1.
Jenal M; Trinh E; Britschgi C; Britschgi A; Roh V; Vorburger SA; Tobler A; Leprince D; Fey MF; Helin K; Tschan MP
Mol Cancer Res; 2009 Jun; 7(6):916-22. PubMed ID: 19491197
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus X protein overcomes stress-induced premature senescence by repressing p16(INK4a) expression via DNA methylation.
Kim YJ; Jung JK; Lee SY; Jang KL
Cancer Lett; 2010 Feb; 288(2):226-35. PubMed ID: 19656618
[TBL] [Abstract][Full Text] [Related]
13. The HMGA1 protoncogene frequently deregulated in cancer is a transcriptional target of E2F1.
Massimi I; Guerrieri F; Petroni M; Veschi V; Truffa S; Screpanti I; Frati L; Levrero M; Gulino A; Giannini G
Mol Carcinog; 2013 Jul; 52(7):526-34. PubMed ID: 22389255
[TBL] [Abstract][Full Text] [Related]
14. Senescence-dependent MutS alpha dysfunction attenuates mismatch repair.
Chang IY; Jin M; Yoon SP; Youn CK; Yoon Y; Moon SP; Hyun JW; Jun JY; You HJ
Mol Cancer Res; 2008 Jun; 6(6):978-89. PubMed ID: 18567801
[TBL] [Abstract][Full Text] [Related]
15. Regulation of dihydrofolate reductase gene expression and E2F components in human diploid fibroblasts during growth and senescence.
Good L; Dimri GP; Campisi J; Chen KY
J Cell Physiol; 1996 Sep; 168(3):580-8. PubMed ID: 8816912
[TBL] [Abstract][Full Text] [Related]
16. Lsh controls silencing of the imprinted Cdkn1c gene.
Fan T; Hagan JP; Kozlov SV; Stewart CL; Muegge K
Development; 2005 Feb; 132(4):635-44. PubMed ID: 15647320
[TBL] [Abstract][Full Text] [Related]
17. Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance.
Alonso MM; Fueyo J; Shay JW; Aldape KD; Jiang H; Lee OH; Johnson DG; Xu J; Kondo Y; Kanzawa T; Kyo S; Bekele BN; Zhou X; Nigro J; McDonald JM; Yung WK; Gomez-Manzano C
J Natl Cancer Inst; 2005 Nov; 97(21):1589-600. PubMed ID: 16264179
[TBL] [Abstract][Full Text] [Related]
18. E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M.
Polzin RG; Benlhabib H; Trepel J; Herrera JE
Gene; 2004 Oct; 341():209-18. PubMed ID: 15474303
[TBL] [Abstract][Full Text] [Related]
19. Decrease of p400 ATPase complex and loss of H2A.Z within the p21 promoter occur in senescent IMR-90 human fibroblasts.
Lee K; Lau ZZ; Meredith C; Park JH
Mech Ageing Dev; 2012; 133(11-12):686-94. PubMed ID: 23146670
[TBL] [Abstract][Full Text] [Related]
20. [Molecular regulation of KIR3DL1 gene expression by transcription factor E2F1].
Gao XN; Yu L
Zhonghua Xue Ye Xue Za Zhi; 2008 Dec; 29(12):806-10. PubMed ID: 19176033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
